MétaCan
Menu
Back to cohort
Record W2991564522 · doi:10.1001/jamaoncol.2018.2706

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016

2018· review· en· W2991564522 on OpenAlexaff
Christina Fitzmaurice, Tomi Akinyemiju, Faris Lami, Shazia Alam, Reza Alizadeh‐Navaei, Christine A. Allen, Ubai Alsharif, Nelson Alvis‐Guzmán, Erfan Amini, Benjamin O. Anderson, Olatunde Aremu, Al Artaman, Solomon Weldegebreal Asgedom, Reza Assadi, Tesfay Mehari Atey, Leticia Ávila‐Burgos, Ashish Awasthi, Huda Omer Ba Saleem, Aleksandra Barać, James R. Bennett, Isabela M. Benseñor, Nickhill Bhakta, Hermann Brenner, Lucero Cahuana-Hurtado, Carlos A Castañeda-Orjuela, Ferrán Catalá-López, Jee-Young J Choi, Devasahayam Jesudas Christopher, Sheng‐Chia Chung, María Paula Curado, Lalit Dandona, Rakhi Dandona, José das Neves, Subhojit Dey, Samath Dhamminda Dharmaratne, David Teye Doku, Tim Driscoll, Manisha Dubey, Hedyeh Ebrahimi, Dumessa Edessa, Ziad El‐Khatib, Aman Yesuf Endries, Florian Fischer, Lisa M Force, Kyle J Foreman, Solomon Weldemariam Gebrehiwot, Sameer Vali Gopalani, Giuseppe Grosso, Rahul Gupta, Bishal Gyawali, Randah R Hamadeh, Samer Hamidi, James Harvey, Hamid Yimam Hassen, Roderick J. Hay, Simon I Hay, Behzad Heibati, Molla Kahssay Hiluf, Nobuyuki Horita, Hung Chak Ho, Olayinka Stephen Ilesanmi, Kaire Innos, Farhad Islami, Mihajlo Jakovljević, Sarah Charlotte Johnson, Jost B Jonas, Amir Kasaeian, Tesfaye Kassa, Yousef Khader, Ejaz Ahmad Khan, Gulfaraz Khan, Young‐Ho Khang, Mohammad Hossein Khosravi, Jagdish Khubchandani, Jacek A Kopec, G Anil Kumar, Michael Kutz, Deepesh Lad, Alessandra Lafranconi, Qing Lan, Yirga Legesse, James Leigh, Shai Linn, Raimundas Lunevičius, Azeem Majeed, Reza Malekzadeh, Déborah Carvalho Malta, LG Mantovani, Brian J. McMahon, Toni Meier, Yohannes Adama Melaku, Mulugeta Melku, Peter Memiah, Walter Mendoza, Tuomo J Meretoja, Haftay Berhane Mezgebe, Ted R. Miller, Shafiu Mohammed, Ali H. Mokdad, Mahmood Moosazadeh, Paula Moraga, Seyyed Meysam Mousavi, Vinay Nangia, Cuong Tat Nguyen, Vuong Minh Nong, Felix Akpojene Ogbo, Andrew T Olagunju, P A Mahesh, Eun‐Kee Park, Tejas Patel, David M. Pereira, Farhad Pishgar, Maarten J. Postma, Farshad Pourmalek, Mostafa Qorbani, Anwar Rafay, Salman Rawaf, David Laith Rawaf, Gholamreza Roshandel, Saeid Safiri, Hamideh Salimzadeh, Juan Sanabria, Milena M Santric-Milicevic, Benn Sartorius, Maheswar Satpathy, Sadaf G Sepanlou, Katya Anne Shackelford, Masood Ali Shaikh, Mahdi Sharif-Alhoseini, Jun She, Min‐Jeong Shin, Ivy Shiue, Mark G. Shrime, Abiy H Sinke, Mekonnen Sisay, Amber Sligar, Mu’awiyyah Babale Sufiyan, Bryan L. Sykes, Rafael Tabarés‐Seisdedos, Gizachew Assefa Tessema, Roman Topór-Mądry, Tung Thanh Tran, Bach Xuan Tran, Kingsley Nnanna Ukwaja, Vasily Vlassov, Elisabete Weiderpass, Hywel C Williams, Nigus Bililign Yimer, Naohiro Yonemoto, Mustafa Z Younis, Christopher J L Murray, Mohsen Naghavi

Bibliographic record

VenueJAMA Oncology · 2018
Typereview
Languageen
FieldMedicine
TopicGlobal Cancer Incidence and Screening
Canadian institutionsUniversity of British ColumbiaOttawa HospitalUniversity of Manitoba
FundersMedical Research CouncilCollege of Medicine, Seoul National UniversityUniversity of California, IrvineLaboratório Associado para a Química VerdeWestern Sydney UniversityAlborz University of Medical SciencesFakultet Medicinskih Nauka, Univerziteta U KragujevcuUniversity of PeradeniyaHelsingin YliopistoNational Research University Higher School of EconomicsChristian Medical College, VelloreTampereen YliopistoUniversity of HaifaUniversitair Medisch Centrum GroningenHaramaya UniversityInyuvesi Yakwazulu-NataliUniversity of GondarUniversidade Federal de Minas GeraisGolestan University of Medical SciencesTehran University of Medical Sciences and Health ServicesMazandaran University of Medical SciencesSamara UniversityUnited Nations Population FundKarolinska InstitutetUniversidade do PortoSeoul National UniversityRijksuniversiteit GroningenNational Institute for Health and Care ResearchJordan University of Science and TechnologyUniversity of OxfordSamfundet FolkhälsanMaragheh University of Medical SciencesFudan UniversityAhmadu Bello UniversityUniwersytet Medyczny im. Piastów Slaskich we WroclawiuTrường Đại học Duy TânIran University of Medical SciencesRede de Química e TecnologiaUniversity of West FloridaNational Cancer InstituteUniversity College LondonMekelle UniversityArabian Gulf UniversityCase Western Reserve UniversityUniversitetet i TromsøBaqiyatallah University of Medical SciencesImperial College LondonJohns Hopkins UniversityCurtin University of TechnologyUniversity of WashingtonAarhus UniversitetUnited Arab Emirates UniversityJackson State UniversityKorea UniversitySouth African Medical Research CouncilKing's College LondonPublic Health Foundation of IndiaUniversität BielefeldKosin UniversityBall State UniversityUniwersytet Jagielloński Collegium Medicum
KeywordsMedicineYears of potential life lostCancerPopulationDisease burdenGlobal healthDemographyEpidemiologyIncidence (geometry)Environmental healthGerontologyPublic healthLife expectancyPathologyInternal medicine

Abstract

fetched live from OpenAlex

Importance: The increasing burden due to cancer and other noncommunicable diseases poses a threat to human development, which has resulted in global political commitments reflected in the Sustainable Development Goals as well as the World Health Organization (WHO) Global Action Plan on Non-Communicable Diseases. To determine if these commitments have resulted in improved cancer control, quantitative assessments of the cancer burden are required. Objective: To assess the burden for 29 cancer groups over time to provide a framework for policy discussion, resource allocation, and research focus. Evidence Review: Cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life-years (DALYs) were evaluated for 195 countries and territories by age and sex using the Global Burden of Disease study estimation methods. Levels and trends were analyzed over time, as well as by the Sociodemographic Index (SDI). Changes in incident cases were categorized by changes due to epidemiological vs demographic transition. Findings: In 2016, there were 17.2 million cancer cases worldwide and 8.9 million deaths. Cancer cases increased by 28% between 2006 and 2016. The smallest increase was seen in high SDI countries. Globally, population aging contributed 17%; population growth, 12%; and changes in age-specific rates, -1% to this change. The most common incident cancer globally for men was prostate cancer (1.4 million cases). The leading cause of cancer deaths and DALYs was tracheal, bronchus, and lung cancer (1.2 million deaths and 25.4 million DALYs). For women, the most common incident cancer and the leading cause of cancer deaths and DALYs was breast cancer (1.7 million incident cases, 535 000 deaths, and 14.9 million DALYs). In 2016, cancer caused 213.2 million DALYs globally for both sexes combined. Between 2006 and 2016, the average annual age-standardized incidence rates for all cancers combined increased in 130 of 195 countries or territories, and the average annual age-standardized death rates decreased within that timeframe in 143 of 195 countries or territories. Conclusions and Relevance: Large disparities exist between countries in cancer incidence, deaths, and associated disability. Scaling up cancer prevention and ensuring universal access to cancer care are required for health equity and to fulfill the global commitments for noncommunicable disease and cancer control.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.011
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.040
Threshold uncertainty score0.079

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.011
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.003
Bibliometrics0.0060.011
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.187
GPT teacher head0.449
Teacher spread0.262 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1,542
Published2018
Admission routes1
Has abstractyes

Explore more

Same venueJAMA OncologySame topicGlobal Cancer Incidence and ScreeningFrench-language works237,207